These five stocks are generating significant attention and could offer strong opportunities for growth across sectors like biotech, tech, energy, and medical devices.
Intelligent Bio Solutions (NASDAQ: INBS) announcing preliminary Q4 revenue up 64% YoY today. While on Friday, September 6, 2024, closed the regular trading session at $1.58, up 22.48%, surpassing its 50-day moving average of $1.45. The session saw a trading volume of 166,871 shares, equating to approximately $250K in dollar volume. In after-hours trading, INBS continued its ascent, soaring 30.38% to close at $2.06 on 4,165,309 shares equating to approximately $8.17 million in dollar volume, 23x its 60-day average trading volume, placing it firmly in breakout territory. The stock improved its intermediate-term outlook by crossing above 50-day moving average an important trendline. Trading up on heavy volume in pre-market gaining 72.7% to $2.73 in pre-market trading today. If the stock challenges and surpasses its 200-day moving average of $2.93, it could signal a sustained upward trajectory, establishing new higher trading range(s) making INBS a stock to watch closely for continued momentum.
SINTX Technologies (NASDAQ: SINT) announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a key patent related to its innovative ceramic technology. The patent covers methods for bonding bioactive silicon nitride to zirconia-toughened alumina (ZTA), significantly enhancing biomedical properties such as osseointegration and resistance to bacterial colonization. This advancement positions SINTX at the forefront of biomaterial manufacturing for medical devices. CEO Eric K. Olson emphasized that the patent strengthens the company’s portfolio and commitment to developing cutting-edge solutions in the medical field.
Piedmont Lithium (NASDAQ: PLL) strengths position reverses course, by withdrawing its application with the U.S. Department of Energy’s Loan Programs Office due to the high costs involved, as the company focuses on preserving cash amidst a sharp 83% drop in lithium prices over the past year. The mining firm also canceled its Tennessee lithium processing facility project despite securing a $141.7 million government grant and now aims to secure debt financing for 65-75% of its $1 billion North Carolina project. CEO Keith Phillips emphasized the need for financial discipline given market conditions, delaying the project’s timeline and selling shares in Atlantic Lithium to maintain cash reserves.
Kaival Brands Innovations Group Inc. (NASDAQ: KAVL): The exclusive U.S. distributor of BIDI® Stick and global distributor of VEEBA® through Philip Morris Products SA (NYSE: PM), Kaival Brands is making significant strides. On June 24, 2024, the company secured approximately $6 million through a public offering to enhance operations, bolster working capital, and drive expansion. Despite volatility—hitting a 52-week high of $5.96 before dipping to a low of $0.59—Kaival Brands’ low float and strong fundamentals suggest significant upside potential for investors.
Peraso Inc. NASDAQ: PRSO Ladenburg Thalmann issues a buy rating with a $3.75 target after strong Q2 results, highlighting $4.2M in revenue from a 180% surge in mmWave sales, with projections of $16M revenue for 2025. Read entire report.
Intelligent Bio Solutions (NASDAQ: INBS) surges on preliminary reporting a 64% year-over-year increase in Q4 revenue SINTX Technologies (NASDAQ: SINT) solidified its biomaterial leadership with a new patent for ceramic technology. Piedmont Lithium (NASDAQ: PLL) has shifted focus from DOE funding to debt financing for its $1 billion North Carolina project amid a lithium price drop. Kaival Brands (NASDAQ: KAVL) raised $6 million through a public offering, presenting upside potential with its low float. Peraso Inc. (NASDAQ: PRSO) gained a buy rating with a $3.75 target after strong mmWave sales growth.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media ContactCompany Name: The Street ReportsContact Person: EditorEmail: Send EmailCountry: United StatesWebsite: http://www.thestreetreports.com
